Search research articles
Contact Us
Filters
Showing results (921-930 of 962) with videos related to
Page
of 97
Sort By:
Cancer Research
|
November 11, 1998
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice
M Liu, M S Bryant, J Chen, et al.
Bioorganic & Medicinal Chemistry
|
January 1, 1997
Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylation
A K Mallams, F G Njoroge, R J Doll, et al.
Journal of Medicinal Chemistry
|
April 4, 1998
Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine
A K Mallams, R R Rossman, R J Doll, et al.
Leukemia
|
April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
C-H Tsai, H-A Hou, J-L Tang, et al.
Prenatal Diagnosis
|
March 1, 2000
Common trisomy mosaicism diagnosed in amniocytes involving chromosomes 13, 18, 20 and 21: karyotype-phenotype correlations
R Wallerstein, M T Yu, R L Neu, et al.
Leukemia
|
August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
H A Hou, C C Lin, W C Chou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
G K Abou-Alfa, S Qin, B-Y Ryoo, et al.
ESMO Open
|
August 20, 2022
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
M Simonelli, E Garralda, F Eskens, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
August 8, 2015
Inverse relationship between body mass index and mortality in older nursing home residents: a meta-analysis of 19,538 elderly subjects
N Veronese, E Cereda, M Solmi, et al.
Nature
|
October 9, 2024
Quasi-periodic X-ray eruptions years after a nearby tidal disruption event
M Nicholl, D R Pasham, A Mummery, et al.
Page
of 97
Search research articles
Search
Showing results (921-930 of 962) with videos related to
Sort By:
Page
of 97
Cancer Research
|
November 11, 1998
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice
M Liu, M S Bryant, J Chen, et al.
Bioorganic & Medicinal Chemistry
|
January 1, 1997
Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylation
A K Mallams, F G Njoroge, R J Doll, et al.
Journal of Medicinal Chemistry
|
April 4, 1998
Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine
A K Mallams, R R Rossman, R J Doll, et al.
Leukemia
|
April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
C-H Tsai, H-A Hou, J-L Tang, et al.
Prenatal Diagnosis
|
March 1, 2000
Common trisomy mosaicism diagnosed in amniocytes involving chromosomes 13, 18, 20 and 21: karyotype-phenotype correlations
R Wallerstein, M T Yu, R L Neu, et al.
Leukemia
|
August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
H A Hou, C C Lin, W C Chou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
G K Abou-Alfa, S Qin, B-Y Ryoo, et al.
ESMO Open
|
August 20, 2022
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
M Simonelli, E Garralda, F Eskens, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
August 8, 2015
Inverse relationship between body mass index and mortality in older nursing home residents: a meta-analysis of 19,538 elderly subjects
N Veronese, E Cereda, M Solmi, et al.
Nature
|
October 9, 2024
Quasi-periodic X-ray eruptions years after a nearby tidal disruption event
M Nicholl, D R Pasham, A Mummery, et al.
Page
of 97